3.77
0.02 (0.67%)
Previous Close | 3.75 |
Open | 3.75 |
Volume | 388,368 |
Avg. Volume (3M) | 570,059 |
Market Cap | 262,396,528 |
Price / Earnings (Forward) | 17.95 |
Price / Sales | 0.760 |
Price / Book | 0.700 |
52 Weeks Range | |
Earnings Date | 5 Aug 2025 - 11 Aug 2025 |
Profit Margin | -23.34% |
Operating Margin (TTM) | -17.11% |
Diluted EPS (TTM) | -1.15 |
Quarterly Revenue Growth (YOY) | 6.30% |
Total Debt/Equity (MRQ) | 106.78% |
Current Ratio (MRQ) | 1.25 |
Operating Cash Flow (TTM) | 4.57 M |
Levered Free Cash Flow (TTM) | 22.18 M |
Return on Assets (TTM) | -4.15% |
Return on Equity (TTM) | -19.80% |
Market Trend
Short Term | Medium Term | ||
Industry | Health Information Services (US) | Bearish | Mixed |
Health Information Services (Global) | Bearish | Mixed | |
Stock | Health Catalyst, Inc | Bearish | Bearish |
AIStockmoo Score
Analyst Consensus | 1.0 |
Insider Activity | NA |
Price Volatility | 0.5 |
Technical Moving Averages | -2.5 |
Technical Oscillators | -0.5 |
Average | -0.38 |
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings. |
|
Sector | Healthcare |
Industry | Health Information Services |
Investment Style | Small Value |
% Held by Insiders | 2.93% |
% Held by Institutions | 81.54% |
Ownership
Name | Date | Shares Held |
---|---|---|
Daventry Group, Lp | 31 Dec 2024 | 2,509,480 |
52 Weeks Range | ||
Price Target Range | ||
High | 9.00 (Canaccord Genuity, 138.73%) | Buy |
Median | 5.50 (45.89%) | |
Low | 4.00 (Evercore ISI Group, 6.10%) | Hold |
Average | 6.00 (59.15%) | |
Total | 3 Buy, 2 Hold | |
Avg. Price @ Call | 4.05 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Canaccord Genuity | 08 May 2025 | 9.00 (138.73%) | Buy | 4.18 |
Stifel | 08 May 2025 | 5.50 (45.89%) | Hold | 4.18 |
Citigroup | 25 Apr 2025 | 6.50 (72.41%) | Buy | 4.10 |
Keybanc | 16 Apr 2025 | 5.00 (32.63%) | Buy | 3.75 |
Evercore ISI Group | 09 Apr 2025 | 4.00 (6.10%) | Hold | 4.02 |
No data within this time range.
Date | Type | Details |
---|---|---|
01 Jul 2025 | Announcement | Accelerating Measurable Improvement Through Actionable Insights: Health Catalyst Announces the Release of 10 AI-Integrated Data Toolkits on Databricks Marketplace |
20 May 2025 | Announcement | Health Catalyst to Participate in Upcoming Investor Conferences |
07 May 2025 | Announcement | Health Catalyst Reports First Quarter 2025 Results |
29 Apr 2025 | Announcement | Health Catalyst Announces Strategic Partnership with Microsoft to Accelerate AI Adoption and Transformation for Care Delivery Organizations |
17 Apr 2025 | Announcement | Health Catalyst to Announce First Quarter 2025 Operating Results and Host Conference Call on Wednesday, May 7, 2025 |
10 Apr 2025 | Announcement | Health Catalyst Releases Data and Analytics Solution Designed for Community, Regional, and Specialty Health Systems: Health Catalyst Ignite Spark™ |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |